FDA's FOIA fees / United States General Accounting Office, General Government Division.

Bibliographic Details
Corporate Authors:	United States. General Accounting Office United States. General Accounting Office. General Government Division
Language:	English
Published:	Washington, D.C. : [Gaithersburg, Md.] (P.O. Box 6015, Gaithersburg 20884-6015) : The Office ; The Office [distributor], [1993]
Subjects:	United States. > Food and Drug Administration Revitalization Act. United States. > Food and Drug Administration > Information services. Fees, Administrative > United States.
Physical Description:	3 pages ; 28 cm
Format:	Government Document Microfilm Book

Similar Items

FDA resources : comprehensive assessment of staffing, facilities, and equipment needed : report to congressional requesters
Published: (1989)

Changes in FDA structure
Published: (1995)

FDA drug approval : review time has decreased in recent years : report to congressional requesters
Published: (1995)

FDA drug approval : a lengthy process that delays the availability of important new drugs : summary : report to the Subcommittee on Science, Research, and Technology, House Committee on Science and Technology
Published: (1980)

FDA user fees : current measures not sufficient for evaluating effect on public health : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives
Published: (1994)

FDA should reduce expensive antibiotic testing and charge fees which more closely reflect cost of certification : report to the Secretary of Health and Human Services
Published: (1981)

FDA regulations : sustained management attention needed to improve timely issuance : statement of Mark V. Nadel, Associate Director, National and Public Health Issues, Human Resources Division, before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives
by: Nadel, M. V. (Mark V.)
Published: (1992)

FDA import automation : serious management and systems development problems persist : report to the ranking minority member, Committee on Commerce, House of Representatives
Published: (1995)

FDA resources
Published: (1996)

FDA user fees 2012 : how innovation helps patients and jobs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, April 18, 2012.
Published: (2013)

FDA user fees 2012 : how innovation helps patients and jobs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, April 18, 2012.
Published: (2013)

FDA : safeguarding America's health.
Published: (1990)

FDA medical bulletin
Published: (1991)

FDA consumer protection activities--FDA reorganization : hearings, Ninety-first Congress, first and second session ...
Published: (1970)

FDA consumer protection activities--FDA reorganization : hearings, Ninety-first Congress, first and second session ...
Published: (1970)

FDA drug approval : application review times largely reflect FDA goals : report to congressional requesters.
Published: (2020)

FDA Bureau of Foods library and information services user's guide.
Published: (1977)

FDA's approach to reviewing over-the-counter drugs is reasonable, but progress is slow : summary : report to the Congress
Published: (1982)

FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives
by: Hamilton, Mary R.
Published: (1996)

Financial management : FDA's controls over property have improved, but weaknesses remain : report to Congressional requesters
Published: (1999)

A consumer guide to FDA.
Published: (1978)

Answers to questions on selected FDA Bureau of Biologics' regulation activities : report
Published: (1980)

FDA can further improve its adverse drug reaction reporting system : report to the Secretary of Health and Human Services
Published: (1982)

FDA protects the public health : ranks high in public trust.
Published: (2002)

Information technology : FDA needs to establish key plans and processes for guiding systems modernization efforts : report to congressional requesters.
Published: (2009)

We want you to know about today's FDA.
Published: (1978)

We want you to know about today's FDA.
Published: (1974)

FDA medical bulletin.
Published: (1991)

La FDA protege la salud pública : ocupa lugar alto en la confianza pública.
Published: (2002)

Science at the FDA : the mainstay of public health protection, new technology is FDA's greatest challenge.
Published: (2002)

FDA's growing responsibilities for the year 2001 and beyond.
Published: (2001)

Drugs and the FDA safety, efficacy, and the public's trust
by: Sekeres, Mikkael A.
Published: (2022)

FDA's reviews of new drugs : changes needed in process for reviewing and reporting on clinical studies : report to the ranking minority member, Special Committee on Aging, U.S. Senate
Published: (1988)

Food and Drug Administration : effect of user fees on drug approval times, withdrawals, and other agency activities : report to the chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate
Published: (2002)

Ciencia en la FDA : la base de la protección de la salud pública ; la nueva tecnología, el reto mayor a la FDA.
Published: (2002)

FDA's approach to reviewing over-the-counter drugs is reasonable, but progress is slow : report to the Congress
Published: (1982)

Allegations of FDA abuses of authority : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, July 25, November 15, and December 5, 1995.
Published: (1996)

Allegations of FDA abuses of authority : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, July 25, November 15, and December 5, 1995.
Published: (1996)

Allegations of FDA abuses of authority : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, July 25, November 15, and December 5, 1995.
Published: (1996)

The FDA
by: Lucas, Scott, 1937-
Published: (1978)